These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 415868

  • 1. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
    [Abstract] [Full Text] [Related]

  • 2. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978 Dec; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 3. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):1-5. PubMed ID: 902672
    [Abstract] [Full Text] [Related]

  • 4. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Aug 17; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P, Donker AJ, Leenen FH.
    Clin Sci Mol Med; 1978 Jan 17; 54(1):75-83. PubMed ID: 620496
    [Abstract] [Full Text] [Related]

  • 6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Aust N Z J Med; 1976 Aug 17; 6(3 Suppl):48-52. PubMed ID: 1071403
    [Abstract] [Full Text] [Related]

  • 7. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH, Streeten DH, Dalakos TG.
    Circ Res; 1977 Mar 17; 40(3):243-50. PubMed ID: 837471
    [Abstract] [Full Text] [Related]

  • 8. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
    Waks UA, Maxwell MH, Marks L, Zawada ET, Kaufman JJ.
    Circulation; 1978 Jun 17; 57(6):1165-70. PubMed ID: 639240
    [Abstract] [Full Text] [Related]

  • 9. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
    Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH.
    Am J Med; 1976 May 31; 60(6):825-36. PubMed ID: 1020762
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H, Leth A, McNair A, Giese J.
    Clin Sci (Lond); 1979 Dec 31; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.
    Klin Wochenschr; 1978 Dec 31; 56 Suppl 1():97-105. PubMed ID: 732257
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA, Dawes PM.
    Aust N Z J Med; 1976 Aug 31; 6(3 Suppl):53-4. PubMed ID: 1071404
    [Abstract] [Full Text] [Related]

  • 13. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 31; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 14. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E, Brown JJ, Brown WC, Fraser R, Trust PM, Lever AF, Morton JJ, Robertson JI.
    Clin Endocrinol (Oxf); 1979 Mar 31; 10(3):227-34. PubMed ID: 455738
    [Abstract] [Full Text] [Related]

  • 15. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ, Boyd GW, Peart WS.
    Circ Res; 1975 Nov 31; 37(5):640-6. PubMed ID: 1192561
    [Abstract] [Full Text] [Related]

  • 16. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 17. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET, Anderson GH, Goldman SH, Streeten DH.
    Kidney Int; 1976 Jun 01; 9(6):511-9. PubMed ID: 940284
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II blockade in normal subjects and essential hypertensive patients.
    MacGregor GA, Dawes PM.
    Clin Sci Mol Med Suppl; 1976 Dec 01; 3():193s-196s. PubMed ID: 1071606
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR, Gavras H, Ribeiro AB, Posternak L.
    Prog Biochem Pharmacol; 1976 Dec 01; 12():145-62. PubMed ID: 1019161
    [Abstract] [Full Text] [Related]

  • 20. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M, Ueno Y, Suruda H, Mohara O, Nishio I, Masuyama Y.
    Jpn Circ J; 1983 Mar 01; 47(3):336-41. PubMed ID: 6339771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.